<DOC>
	<DOCNO>NCT01493882</DOCNO>
	<brief_summary>The purpose study evaluate efficacy , safety tolerability JNJ-39758979 compare placebo patient uncontrolled asthma despite current treatment inhale corticosteroid and/or long-acting beta 2-agonist ( LABA ) and/or montelukast least 4 week .</brief_summary>
	<brief_title>Study JNJ-39758979 Symptomatic Adult Patients With Uncontrolled Asthma</brief_title>
	<detailed_description>This two-part study ; part study ( Part 1 Part 2 ) approximately 34 week duration include 4-week screening phase , 24-week placebo-controlled treatment phase six-week follow-up phase . In Part 1 , patient randomly assign receive placebo JNJ-39758979 300 mg daily Week 24 . In Part 2 , patient randomly assign 1 4 treatment group receive treatment placebo , 30 mg , 100 mg , 300 mg JNJ-39758979 daily Week 24 . Safety assessment evaluation determine efficacy JNJ-39758979 reduce sign symptom asthma perform daily basis via electronic diary study visit .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>Has diagnosis asthma least 6 month screen . Has receive inhale corticosteroid ( ≤ 1000 µg fluticasone equivalent ) alone conjunction longacting Beta 2agonist ( salmeterol , formoterol , etc . ) and/or montelukast . Have ACQ score ≥ 1.5 screening . Must healthy medically stable basis physical examination , medical history , vital sign , 12lead electrocardiogram ( ECG ) perform screen Must postmenopausal premenopausal , must use acceptable method birth control . Has ever lifethreatening asthma attack include respiratory arrest , intubation , intensive care unit admission due asthma . Has history chronic respiratory condition include chronic obstructive pulmonary disease , bronchiolitis , bronchiectasis , allergic bronchopulmonary aspergillosis ( mycosis ) , occupational asthma , sleep apnea pulmonary hypertension.Has initiate discontinue allergen immunotherapy within 12 week screen . Has smoke within 3 year screen history smoking ≥ 10 pack year ( 1 pack year = 20 cigarette smoke per day 1 year ) equivalent , positive urine cotinine test Screening . Has know malignancy history malignancy exception basal cell carcinoma squamous cell carcinoma . Has chronic recurrent infectious disease , include , limited : active tuberculosis.Has clinically significant , acute respiratory infection within 4 week screen . Has substance abuse ( drug alcohol ) problem within previous 3 year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Uncontrolled Persistent Asthma , Dyspnea , Wheezing</keyword>
</DOC>